Sabra Healthcare REIT Inc. (SBRA) PT Raised to $22 at Scotiabank
Tweet
Share
E-mailGet Alerts SBRA Hot Sheet
Price: $18.27 +0.83%
Rating Summary:
9 Buy, 16 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Rating Summary:
9 Buy, 16 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Join SI Premium – FREE
Scotiabank analyst Nicholas Yulico raised the price target on Sabra Healthcare REIT Inc. (NASDAQ: SBRA) to $22.00 (from $21.00) while maintaining a Sector Perform rating.
You May Also Be Interested In
- Citi Downgrades Sabra Healthcare REIT Inc. (SBRA) to Neutral
- Deutsche Bank Downgrades Apogee Therapeutics Inc (APGE) to Hold
- FedEx (FDX) PT Lowered to $424 at Bernstein SocGen Group
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
